August 28, 2016 9:39 AM ET


Company Overview of Syros Pharmaceuticals, Inc.

Executive Profile

Nancy A. Simonian M.D.

Chief Executive Officer, President and Director, Syros Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Nancy A. Simonian, M.D., has been the Chief Executive Officer at Syros Pharmaceuticals, Inc. since July 2012 and serves as its President. Dr. Simonian served as the Chief Medical Officer of Clinical, Medical & Regulatory Affairs at Millennium Pharmaceuticals, Inc. She served as the Chief Medical Officer of Millennium Pharmaceuticals Inc. since 2006. While at Millennium, Dr. Simonian has built a strong clinical development organization which effectively executes on ...

Corporate Headquarters

620 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-744-1340
Fax: --

Board Members Memberships

Director and Chairman of Nominating & Corporate Governance Committee
Chief Executive Officer, President and Director


Princeton University
University of Pennsylvania - School of Medicine

Other Affiliations

Annual Compensation

Total Annual Compensation$425,000

Stocks Options

All Other Compensation$270
Exercisable Options$90,681
Unexercisable Options$329,987
Total Number of Options$420,668

Total Compensation

Total Annual Cash Compensation$425,270
Total Short Term Compensation$425,000
Other Long Term Compensation$270
Total Calculated Compensation$1,148,518

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syros Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at